AltaBioscience provides an analytical service for the quantification and profiling of urinary steroid metabolites as biomarkers of Adrenal Cortical Carcinoma (ACC) using gas chromatography-mass spectrometry, GC-MS. The service provides the accurate quantitation of 32 urinary steroids and includes a report detailing probability of malignancy as determined by our exclusive licence on this patented computational assay.
Developed by Professor Wiebke Arlt (William Withering Chair of Medicine and Director of the Institute of Metabolism and Systems Research, IMSR, at the Centre for Endocrinology, Diabetes and Metabolism (CEDAM) University of Birmingham), this technique has significant advantages over current diagnostic procedures, which rely on CT/MRI imaging or tissue biopsy – both of which are time-consuming and costly, and rely on indicators that can be ambiguous.
The assay is currently only available for research use only.
Our sample information page provides details of sample requirements and a sample submission form for you to download.